XBiotech Inc. (XBIT) KPIs and segments
Close on Nov 13, 2026Market cap $59.76MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive XBiotech's business
XBiotech's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Manufacturing Revenue($M) | 0 | 0 | 0 | 0.30 | 1.68 | 1.53 | 0.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | |
Clinical Trial Service Revenue($M) | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.03 | 0.35 | 0.75 | ||||
Manufacturing Revenue($M) | 0 | 0 | 0.28 | 1.47 | 1.32 | 0.29 | 3.45 | 3.41 | 3.16 | 2.47 | 3.19 | ||
Clinical Trial Service Revenue($M) | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.01 | 0.08 | -0.20 | ||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2023-11-09.
See a number that looks wrong?